EMAIL THIS PAGE TO A FRIEND

PloS one

Combination effect of epigenetic regulation and ionizing radiation in colorectal cancer cells.


PMID 25136811

Abstract

Exposure of cells to ionizing radiation (IR) induces, not only, activation of multiple signaling pathways that play critical roles in cell fate determination, but also alteration of molecular pathways involved in cell death or survival. Recently, DNA methylation has been established as a critical epigenetic process involved in the regulation of gene expression in cancer cells, suggesting that DNA methylation inhibition may be an effective cancer treatment strategy. Because alterations of gene expression by DNA methylation have been considered to influence radioresponsiveness, we investigated the effect of a DNA methyltransferase inhibitor, 5-aza-2'-deoxycytidine (5-aza-dC), on radiosensitivity. In addition, we investigated the underlying cellular mechanisms of combination treatments of ionizing irradiation (IR) and 5-aza-dC in human colon cancer cells. Colon cancer cell lines were initially tested for radiation sensitivity by IR in vitro and were treated with two different doses of 5-aza-dC. Survival of these cell lines was measured using MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) and clonogenic assays. The effects of 5-aza-dC along with irradiation on cell growth, cell cycle distribution, apoptosis, and apoptosis-related gene expression were examined. Combination irradiation treatment with 5-aza-dC significantly decreased growth activity compared with irradiation treatment alone or with 5-aza-dC treatment alone. The percentage of HCT116 cells in the sub-G1 phase and their apoptotic rate was increased when cells were treated with irradiation in combination with 5-aza-dC compared with either treatment alone. These observations were strongly supported by increased caspase activity, increased comet tails using comet assays, and increased protein levels of apoptosis-associated molecules (caspase 3/9, cleaved PARP). Our data demonstrated that 5-aza-dC enhanced radiosensitivity in colon cancer cells, and the combination effects of 5-aza-dC with radiation showed greater cellular effects than that of single treatment, suggesting that the combination of 5-aza-dC and radiation has the potential to become a clinical strategy for the treatment of cancer.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB1405470
Anti-BIRC5 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA002830
Anti-BIRC5 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
HPA001473
Anti-CASP9 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB4503332
Anti-CASP9 antibody produced in rabbit, affinity isolated antibody
SAB4503333
Anti-CASP9 antibody produced in rabbit, affinity isolated antibody
SAB4503334
Anti-CASP9 antibody produced in rabbit, affinity isolated antibody
SAB4503335
Anti-CASP9 antibody produced in rabbit, affinity isolated antibody
C7729 Anti-Caspase 9 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB4300683
Anti-Caspase 9 antibody produced in rabbit, affinity isolated antibody
SAB3500405
Anti-Caspase-9 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
S8191
Anti-Survivin antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
SAB3500269
Anti-Survivin antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB4501460
Anti-Survivin antibody produced in rabbit, affinity isolated antibody
WH0000332M1
Monoclonal Anti-BIRC5 antibody produced in mouse, clone 5B10, purified immunoglobulin, buffered aqueous solution
SAB4100131
Monoclonal Anti-BIRC5 antibody produced in mouse, clone BIRC5-A113, culture supernatant
SAB5300510 Monoclonal Anti-BIRC5 antibody produced in mouse, clone 2H5H2, ascites fluid
SAB5300511
Monoclonal Anti-BIRC5 antibody produced in mouse, clone 1H5, purified immunoglobulin, buffered aqueous solution
WH0000842M1
Monoclonal Anti-CASP9 antibody produced in mouse, clone 3B8-4G2, purified immunoglobulin, buffered aqueous solution
SAB1403634
Monoclonal Anti-CASP9 antibody produced in mouse, clone 4F12-G6, purified immunoglobulin, buffered aqueous solution
C4356
Monoclonal Anti-Caspase 9 antibody produced in mouse, ~2 mg/mL, clone CAS9, purified immunoglobulin, buffered aqueous solution